1. Home
  2. KOS vs EVO Comparison

KOS vs EVO Comparison

Compare KOS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kosmos Energy Ltd. (DE)

KOS

Kosmos Energy Ltd. (DE)

HOLD

Current Price

$2.34

Market Cap

1.1B

Sector

Energy

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.29

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOS
EVO
Founded
2003
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
KOS
EVO
Price
$2.34
$3.29
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$1.76
$7.00
AVG Volume (30 Days)
16.5M
147.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,675,358,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.47
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$2.84
52 Week High
$2.44
$4.80

Technical Indicators

Market Signals
Indicator
KOS
EVO
Relative Strength Index (RSI) 69.21 41.03
Support Level $1.52 $2.87
Resistance Level $2.43 $3.78
Average True Range (ATR) 0.20 0.09
MACD 0.05 -0.03
Stochastic Oscillator 80.29 7.41

Price Performance

Historical Comparison
KOS
EVO

About KOS Kosmos Energy Ltd. (DE)

Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: